Johnson & Johnson Common Stock (NYSE:JNJ):
Johnson & Johnson to Participate in the 25th Annual Credit Suisse Health Care Conference.
In the market the company is trading down since yesterday’s close of $115.7.
The company recently declared a dividend for shareholders that will be paid on Tue Dec 6, 2016. The dividend will be $0.800 per share for the quarter which is $3.20 annualized. This dividend amount will represent a yeild of $2.81. The ex-dividend date will be Friday August 19th, 2016.
It is currently trading at $115.33 which is marginally lower than $117.51, the 50 day moving average and barely below the 200 day moving average of $117.79. The 50 day moving average was down $-2.18 or -1.85% and the 200 day average moved down $-2.46.
The company currently has a P/E ratio of 20.24 and the market cap of the company is 315.53B. As of the last earnings report the EPS was $5.70 and is expected to be $6.72 for the current year with 2,735,876,000 shares currently outstanding. Next quarter’s EPS is forecasted to be $1.76 with next year’s EPS anticipated to be $7.14.
Several ratings analysts have provided guidance on JNJ of late. September 13 investment analysts at Jefferies maintained a company rating of “Hold” and raised the price target to $115.00 from $109.00. On July 20 the stock rating was upgraded to “Hold” from “Neutral” with a current price target of $113.00 by Argus Research.
Equity analyst Argus Research lowered the price target and upgraded the stock on July 20 changing the price objective from $114.00 to $113.00 and raising the rating from “Neutral” to “Hold”. On June 14 Jefferies made no change to the stock rating of “Hold” and raised the price expectation from $99.00 to $109.00.
On May 20, 2016 Standpoint Research initiated coverage setting a rating of “Sell”. On May 1 Credit Suisse kept the company rating at “Neutral” but moved up the price target from $100.00 to $112.00.